The oral peptide problem
Peptides are normally destroyed in the gut, which is why almost every peptide drug is injected.
How a peptide becomes a pill, and what nobody has published
Peptides are normally destroyed in the gut, which is why almost every peptide drug is injected. Amycretin is unusual for being developed as a once-daily tablet as well as a weekly injection, and the oral form has been through a first-in-human trial and a phase 2 dose-finding trial.
This unit explains why oral peptides are hard, what the amycretin tablet trials actually tested, and one thing worth naming plainly: no published source describes how the tablet gets across the gut wall, or what fraction of a dose is absorbed. The gap is part of the subject.
Key terms
Why peptides fail in the gut
The gut is built to digest proteins and peptides, so swallowing a peptide drug normally destroys it. The general statement of the problem comes from the oral-semaglutide literature and is quoted here for the principle rather than for amycretin: oral administration of therapeutic peptides is hindered by poor absorption across the gastrointestinal barrier and by extensive degradation by proteolytic enzymes.
Two problems compound each other: degradation by enzymes, and poor crossing of the gut wall. Solving only one is not enough, which is why oral peptide delivery took decades to achieve for any molecule at all. That amycretin has an oral arm in trials at all is the notable fact; how it is done is the part the record does not tell us.
AdvancedWhy a protective coating is not the answer on its own
Coatings can shield a drug from stomach acid, but they do nothing about the second and harder problem, getting a large water-loving molecule through the gut wall. The general statement in the literature is that oral peptide delivery is hindered by poor absorption across the gut barrier, so crossing it is not something a peptide does unaided. So an oral peptide product needs both protection and active help with absorption, and the engineering for each molecule is specific enough that it cannot be assumed from another drug in the same class.